Five10K should position itself as a strategic partner that enables medical device companies to navigate FDA cybersecurity requirements with confidence, efficiency, and speed.

At its core, the company should provide end-to-end cybersecurity readiness for FDA submissions, supporting both 510(k) and PMA pathways. This includes ensuring that your product meets current regulatory expectations while minimizing the risk of delays, rejections, or costly rework.

Beyond submission readiness, Five10K should deliver holistic risk management across the product lifecycle, aligned with standards such as ISO 14971. This means identifying, quantifying, and mitigating cybersecurity risks early—before they become regulatory or commercial obstacles.

Equally important is support for a secure and compliant development process. By aligning with IEC 62304 and FDA guidance, Five10K should help your teams integrate cybersecurity into the software lifecycle—reducing technical debt and strengthening product resilience from day one.

From a technical standpoint, the company should offer targeted security validation, including penetration testing and vulnerability assessments tailored specifically to connected medical devices and their ecosystems.

On the regulatory side, Five10K should take ownership of critical documentation and submission assets—from cybersecurity risk management reports to SBOMs and postmarket plans—ensuring they are audit-ready and aligned with FDA expectations.

Importantly, the relationship should not end at submission. Five10K should provide ongoing compliance and postmarket support, helping your organization stay ahead of evolving threats and regulatory changes while protecting both patients and your brand.

Finally, as a trusted advisor, Five10K should offer strategic guidance at the executive level—supporting decision-making, preparing for audits, and identifying gaps early—so that cybersecurity becomes a business enabler rather than a bottleneck.

Getting started is straightforward and designed to deliver clarity from day one.

We begin with a focused Cybersecurity Readiness Assessment, where we evaluate your current product, development processes, and regulatory preparedness against FDA expectations. This initial step is structured to quickly identify gaps, risks, and opportunities—without disrupting your ongoing operations.

Following the assessment, you will receive a clear, executive-level roadmap outlining what is required to achieve compliance and readiness for submission. This includes prioritized actions, timelines, and the level of effort needed, enabling you to make informed business decisions with confidence.

From there, we work alongside your team to implement the necessary controls, documentation, and processes, ensuring alignment with standards such as ISO 14971 and IEC 62304, as well as current FDA cybersecurity guidance.

Throughout the engagement, our focus remains on efficiency and predictability—helping you avoid delays, reduce regulatory friction, and accelerate your path to market.

In short, the process begins with insight, continues with structured execution, and results in full cybersecurity readiness—without unnecessary complexity.

What sets us apart is our ability to bridge the gap between deep cybersecurity expertise and real-world FDA execution—with a clear focus on business outcomes.

Unlike traditional cybersecurity firms that operate at a purely technical level, we are built specifically for the medical device regulatory environment. We understand not only how to secure your product, but how to ensure that every decision, control, and document aligns with FDA expectations.

Equally important, we are not a generic consulting body. We operate as a hands-on partner, working directly with your teams to implement solutions—not just recommend them. Our approach is pragmatic, efficient, and tailored to your product and stage of development.

Our track record reflects this approach. Solutions developed under our methodology are currently deployed in over 6,500 hospitals worldwide, with zero cybersecurity incidents, and no findings, non-conformities, or CAPAs related to cybersecurity. This level of consistency is the result of disciplined execution and a deep understanding of both risk and regulation.

We also differentiate ourselves through speed and precision. Our methodology is designed to eliminate unnecessary complexity, prioritize what truly matters for submission, and help you avoid costly delays or rework.

Finally, we approach cybersecurity not as a compliance burden, but as a strategic enabler—one that protects patients, strengthens your product, and supports faster, more predictable market entry.

You can reach us anytime via our contact page or email. We aim to respond quickGetting in touch with us is simple and designed to fit your schedule.

You can reach out directly through our website to schedule an initial consultation, where we will discuss your product, current stage, and regulatory goals. This first conversation is focused, confidential, and aimed at providing immediate value.

Alternatively, you are welcome to contact us via email or request a call, and a member of our team will respond promptly to coordinate next steps.

We prioritize responsiveness and clarity—so from the very first interaction, you can expect a professional, efficient, and business-focused engagement.
Email:

ProductSecurity@five10K.com

Our pricing model is designed to be transparent, flexible, and aligned with your business objectives.

We typically structure engagements based on the scope, complexity, and stage of your product, rather than applying a one-size-fits-all model. This ensures that you invest only in what is truly required to achieve regulatory readiness and cybersecurity maturity.

We usually begin with a fixed-fee Cybersecurity Readiness Assessment, providing you with a clear understanding of gaps, risks, and the path forward. From there, implementation can be structured as either:

• Project-based pricing for defined deliverables (e.g., FDA submission support, documentation, risk management), or

• Ongoing partnership (retainer model) for continuous support, compliance, and postmarket activities.

Our focus is on predictability and efficiency—minimizing unexpected costs while accelerating your time to market.

Working with us is designed to be clear, efficient, and outcome-driven.

From the outset, we operate as an extension of your team—not as an external advisor. We take the time to understand your product, your timelines, and your regulatory objectives, so that every step is aligned with your business priorities.

Our engagement model is highly structured yet pragmatic. We focus on what truly matters for FDA readiness and cybersecurity, eliminating unnecessary complexity and avoiding theoretical work that does not translate into real progress.

You can expect direct communication, fast turnaround times, and full transparency throughout the process. We provide clear deliverables, well-defined milestones, and executive-level visibility, so there are no surprises.

Importantly, we are hands-on. We don’t just advise—we work alongside your teams to implement, document, and validate everything required for submission and beyond.

The result is a partnership that brings confidence, predictability, and momentum—helping you move forward faster while reducing regulatory risk.